James Howard-Tripp

James Howard-Tripp

Amministratore Delegato presso STAGEZERO LIFE SCIENCES LTD.
Health Technology
Health Services

Profilo

James R.
Howard-Tripp
is currently the Executive Chairman & Chief Executive Officer at StageZero Life Sciences Ltd. He is also the Chief Executive Officer at Innovative Diagnostic Laboratory LLP, the President & Director at GeneNews (USA), Inc., and a Founding Member of the Canadian Healthcare Licensing Association.
Previously, he served as the President, Chief Executive Officer & Director at Labopharm, Inc. from 2010 to 2011.
He was also the Chief Executive Officer at Paladin Labs Europe Ltd., the President & Chief Executive Officer at Allelix Neuroscience, Inc., and the Senior Vice President-Operations at Allelix Biopharmaceuticals, Inc. Additionally, he held the position of Vice President-Business Development at Wyeth Ayerst Canada, Inc.

Posizioni attive di James Howard-Tripp

SocietàPosizioneInizio
STAGEZERO LIFE SCIENCES LTD. Amministratore Delegato 10/08/2016
Canadian Healthcare Licensing Association
Corporate Officer/Principal 20/08/2009
Amministratore Delegato -
Presidente -

Precedenti posizioni note di James Howard-Tripp

SocietàPosizioneFine
Amministratore Delegato 14/03/2011
Direttore operativo -
Wyeth Ayerst Canada, Inc.
Corporate Officer/Principal -
Allelix Neuroscience, Inc.
Presidente -
Paladin Labs Europe Ltd.
Presidente -
Vedi nel dettaglio l'esperienza di James Howard-Tripp

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

38

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Technology

Health Technology

Health Technology

Paladin Labs Europe Ltd.

Canadian Healthcare Licensing Association

Allelix Neuroscience, Inc.

Wyeth Ayerst Canada, Inc.

Health Services

Health Technology

  1. Mercati
  2. Insiders
  3. James Howard-Tripp